Get started
Author

Michael Medl

Observed names: M Medl, M. Medl
OpenAlex ID: A5060030173
Real-time spatial compound imaging in breast ultrasound
2002 · Sabine Huber, Monika Wagner, et al. · Ultrasound in Medicine & Biology · 125
Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy
1999 · A. Obermair, M. Geramou, et al. · International Journal of Gynecological Cancer · 76
Color-coded and spectral Doppler flow in breast carcinomas – Relationship with the tumor microvasculature
1998 · Christian Peters-Engl, Michael Medl, et al. · Breast Cancer Research and Treatment · 64
First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer.
2000 · M Medl, C Peters-Engl, et al. · PubMed · 61
Erythropoietin Treatment under Polychemotherapy in Patients with Gynecologic Malignancies: A Prospective, Randomized, Double-Blind Placebo-Controlled Multicenter Study
1997 · Ch. Kurz, Ch. Marth, et al. · Gynecologic Oncology · 54
The use of colour-coded and spectral Doppler ultrasound in the differentiation of benign and malignant breast lesions
1995 · C Peters-Engl, M Medl, et al. · British Journal of Cancer · 52
PDF
Benign Breast Lesions: Minimally Invasive Vacuum-assisted Biopsy with 11-Gauge Needles—Patient Acceptance and Effect on Follow-up Imaging Findings
2003 · Sabine Huber, Monika Wagner, et al. · Radiology · 47
Association between endometrial cancer and tamoxifen treatment of breast cancer
1999 · Christian Peters‐Engl, Wilhelm Frank, et al. · Breast Cancer Research and Treatment · 45
Impact of hysteroscopy on disease-free survival in clinically stage I endometrial cancer patients
2000 · A. Obermair, M. Geramou, et al. · International Journal of Gynecological Cancer · 44
Relevance of sonographic B-mode criteria and computer-aided ultrasonic tissue characterization in differential/diagnosis of solid breast masses
2000 · S Huber, J Danes, et al. · Ultrasound in Medicine & Biology · 40
Vaginal prolapse surgery with transvaginal mesh: results of the Austrian registry
2014 · for the Austrian Urogynecology Working Group, V. Bjelic-Radisic, et al. · International Urogynecology Journal · 39
DNA Amplification of HER-2/neu and INT-2 Oncogenes in Epithelial Ovarian Cancer
1995 · Michael Medl, Paul Sevelda, et al. · Gynecologic Oncology · 39
The application of fibrin glue after axillary lymphadenectomy in the surgical treatment of human breast cancer.
1995 · M Medl, K Mayerhofer, et al. · PubMed · 35
Value of ultrasound and magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses.
2002 · Sabine Huber, Michael Medl, et al. · PubMed · 33
Lunar phases and survival of breast cancer patients – a statistical analysis of 3,757 cases
2001 · Christian Peters-Engl, Wilhelm Frank, et al. · Breast Cancer Research and Treatment · 32
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer
1993 · A Rosen, P Sevelda, et al. · British Journal of Cancer · 32
PDF
Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival
1999 · Christian Peters-engl, Wilhelm Frank, et al. · Breast Cancer Research and Treatment · 29
CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer
1999 · C Peters-Engl, A Obermair, et al. · British Journal of Cancer · 27
PDF
Locally advanced breast carcinoma: computer assisted semiquantitative analysis of color Doppler ultrasonography in the evaluation of tumor response to neoadjuvant chemotherapy (work in progress).
2000 · S Huber, M Medl, et al. · Journal of Ultrasound in Medicine · 26
HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples
1993 · Christa Hruza, Karl Dobianer, et al. · European Journal of Cancer · 25
Magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses.
1995 · M Medl, K J Kulenkampff, et al. · PubMed · 23
Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA125) in patients with epithelial ovarian cancer.
1995 · C Peters-Engl, M Medl, et al. · PubMed · 21
Ultrasonographic tissue characterization in monitoring tumor response to neoadjuvant chemotherapy in locally advanced breast cancer (work in progress).
2000 · S Huber, M Medl, et al. · Journal of Ultrasound in Medicine · 20
Serum levels of the tumour‐associated trypsin inhibitor in patients with endometriosis
1997 · Michael Medl, Emil Ogris, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 19
TATI (tumour-associated trypsin inhibitor) as a marker of ovarian cancer
1995 · M Medl, E Ogris, et al. · British Journal of Cancer · 19
PDF
Works count: 64
Citation count: 1,103
H-index: 21
I10-index: 29
Year
Topic
Type